Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Generation and Characterization of Alloantigen-Specific Regulatory T Cells For Clinical Transplant Tolerance.

Mathew JM, Voss JH, McEwen ST, Konieczna I, Chakraborty A, Huang X, He J, Gallon L, Kornbluth RS, Leventhal JR.

Sci Rep. 2018 Jan 18;8(1):1136. doi: 10.1038/s41598-018-19621-6.

2.

HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunity.

Kanagavelu S, Termini JM, Gupta S, Raffa FN, Fuller KA, Rivas Y, Philip S, Kornbluth RS, Stone GW.

PLoS One. 2014 Feb 28;9(2):e90100. doi: 10.1371/journal.pone.0090100. eCollection 2014.

3.

Vaccination with a fusion protein that introduces HIV-1 gag antigen into a multitrimer CD40L construct results in enhanced CD8+ T cell responses and protection from viral challenge by vaccinia-gag.

Gupta S, Termini JM, Raffa FN, Williams CA, Kornbluth RS, Stone GW.

J Virol. 2014 Feb;88(3):1492-501. doi: 10.1128/JVI.02229-13. Epub 2013 Nov 13.

4.

HIV downregulates interferon-stimulated genes in primary macrophages.

Wie SH, Du P, Luong TQ, Rought SE, Beliakova-Bethell N, Lozach J, Corbeil J, Kornbluth RS, Richman DD, Woelk CH.

J Interferon Cytokine Res. 2013 Feb;33(2):90-5. doi: 10.1089/jir.2012.0052. Epub 2012 Dec 31.

5.

Design of CD40 agonists and their use in growing B cells for cancer immunotherapy.

Kornbluth RS, Stempniak M, Stone GW.

Int Rev Immunol. 2012 Aug;31(4):279-88. doi: 10.3109/08830185.2012.703272. Review.

6.

In this issue: harnessing immunity against difficult targets, through the CD40-CD40L pathway.

Kornbluth RS, Bot A.

Int Rev Immunol. 2012 Aug;31(4):243-5. doi: 10.3109/08830185.2012.702511.

PMID:
22804569
7.

Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine.

Kanagavelu SK, Snarsky V, Termini JM, Gupta S, Barzee S, Wright JA, Khan WN, Kornbluth RS, Stone GW.

Vaccine. 2012 Jan 17;30(4):691-702. doi: 10.1016/j.vaccine.2011.11.088. Epub 2011 Dec 4.

8.

Latent Membrane Protein 1 as a molecular adjuvant for single-cycle lentiviral vaccines.

Gupta S, Termini JM, Niu L, Kanagavelu SK, Rahmberg AR, Kornbluth RS, Evans DT, Stone GW.

Retrovirology. 2011 May 18;8:39. doi: 10.1186/1742-4690-8-39.

9.

EBV LMP1, a viral mimic of CD40, activates dendritic cells and functions as a molecular adjuvant when incorporated into an HIV vaccine.

Gupta S, Termini JM, Niu L, Kanagavelu SK, Schmidtmayerova H, Snarsky V, Kornbluth RS, Stone GW.

J Leukoc Biol. 2011 Aug;90(2):389-98. doi: 10.1189/jlb.0211068. Epub 2011 May 17.

10.

Nanoparticle-delivered multimeric soluble CD40L DNA combined with Toll-Like Receptor agonists as a treatment for melanoma.

Stone GW, Barzee S, Snarsky V, Santucci C, Tran B, Langer R, Zugates GT, Anderson DG, Kornbluth RS.

PLoS One. 2009 Oct 8;4(10):e7334. doi: 10.1371/journal.pone.0007334.

11.

Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.

Grossmann C, Tenbusch M, Nchinda G, Temchura V, Nabi G, Stone GW, Kornbluth RS, Uberla K.

BMC Immunol. 2009 Aug 3;10:43. doi: 10.1186/1471-2172-10-43.

12.

Regression of established AB1 murine mesothelioma induced by peritumoral injections of CpG oligodeoxynucleotide either alone or in combination with poly(I:C) and CD40 ligand plasmid DNA.

Stone GW, Barzee S, Snarsky V, Santucci C, Tran B, Kornbluth RS.

J Thorac Oncol. 2009 Jul;4(7):802-8. doi: 10.1097/JTO.0b013e3181a8634d.

13.
14.

Macaque multimeric soluble CD40 ligand and GITR ligand constructs are immunostimulatory molecules in vitro.

Stone GW, Barzee S, Snarsky V, Spina CA, Lifson JD, Pillai VK, Amara RR, Villinger F, Kornbluth RS.

Clin Vaccine Immunol. 2006 Nov;13(11):1223-30. Epub 2006 Sep 20.

15.

Mutations in the E9L polymerase gene of cidofovir-resistant vaccinia virus strain WR are associated with the drug resistance phenotype.

Kornbluth RS, Smee DF, Sidwell RW, Snarsky V, Evans DH, Hostetler KY.

Antimicrob Agents Chemother. 2006 Dec;50(12):4038-43. Epub 2006 Sep 18.

16.

Immunostimulatory combinations: designing the next generation of vaccine adjuvants.

Kornbluth RS, Stone GW.

J Leukoc Biol. 2006 Nov;80(5):1084-102. Epub 2006 Aug 24. Review.

PMID:
16931603
17.

Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines.

Stone GW, Barzee S, Snarsky V, Kee K, Spina CA, Yu XF, Kornbluth RS.

J Virol. 2006 Feb;80(4):1762-72.

18.

CpG oligonucleotides partially inhibit growth of Mycobacterium tuberculosis, but not Salmonella or Listeria, in human monocyte-derived macrophages.

Wang JP, Hayashi T, Datta SK, Kornbluth RS, Raz E, Guiney DG.

FEMS Immunol Med Microbiol. 2005 Aug 1;45(2):303-10.

19.

Interferon gene expression following HIV type 1 infection of monocyte-derived macrophages.

Woelk CH, Ottones F, Plotkin CR, Du P, Royer CD, Rought SE, Lozach J, Sasik R, Kornbluth RS, Richman DD, Corbeil J.

AIDS Res Hum Retroviruses. 2004 Nov;20(11):1210-22.

PMID:
15588343
20.

An expanding role for CD40L and other tumor necrosis factor superfamily ligands in HIV infection.

Kornbluth RS.

J Hematother Stem Cell Res. 2002 Oct;11(5):787-801. Review.

PMID:
12427285
22.

Enhancement of innate immunity against Mycobacterium avium infection by immunostimulatory DNA is mediated by indoleamine 2,3-dioxygenase.

Hayashi T, Rao SP, Takabayashi K, Van Uden JH, Kornbluth RS, Baird SM, Taylor MW, Carson DA, Catanzaro A, Raz E.

Infect Immun. 2001 Oct;69(10):6156-64.

23.

The emerging role of CD40 ligand in HIV infection.

Kornbluth RS.

J Leukoc Biol. 2000 Sep;68(3):373-82. Review.

PMID:
10985254
24.

Enhancement of antigen-presenting cell surface molecules involved in cognate interactions by immunostimulatory DNA sequences.

Martin-Orozco E, Kobayashi H, Van Uden J, Nguyen MD, Kornbluth RS, Raz E.

Int Immunol. 1999 Jul;11(7):1111-8.

PMID:
10383944
25.

Role of CD40 ligand in Mycobacterium avium infection.

Hayashi T, Rao SP, Meylan PR, Kornbluth RS, Catanzaro A.

Infect Immun. 1999 Jul;67(7):3558-65.

26.

CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines.

Kornbluth RS, Kee K, Richman DD.

Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5205-10.

27.

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

Roman M, Martin-Orozco E, Goodman JS, Nguyen MD, Sato Y, Ronaghy A, Kornbluth RS, Richman DD, Carson DA, Raz E.

Nat Med. 1997 Aug;3(8):849-54.

PMID:
9256274
28.

A continuing enigma: the role of cells of macrophage lineage in the development of HIV disease.

Perno CF, Crowe SM, Kornbluth RS.

J Leukoc Biol. 1997 Jul;62(1):1-3. Review. No abstract available.

PMID:
9225985
29.

Managing HIV. Part 3: Mechanisms of disease. 3.3 How HIV leads to opportunistic infections.

Crowe SM, Kornbluth RS.

Med J Aust. 1996 Feb 5;164(3):171-3.

PMID:
8628138
30.
31.
32.

Interferon interactions with HIV1 in macrophages.

Kornbluth RS, Matsuzaki H, Meylan PR, Richman DD.

Res Immunol. 1994 Oct-Dec;145(8-9):664-6; discussion 666-8. Review. No abstract available.

PMID:
7538687
33.

Significance of T cell apoptosis for macrophages in HIV infection.

Kornbluth RS.

J Leukoc Biol. 1994 Sep;56(3):247-56. Review.

PMID:
8083597
34.

Overview of HIV interactions with macrophages and dendritic cells: the other infection in AIDS.

Crowe SM, Kornbluth RS.

J Leukoc Biol. 1994 Sep;56(3):215-7. Review. No abstract available.

PMID:
8083591
36.

Skin test responses as predictors of tuberculous infection and of progression in HIV-infected persons.

Kornbluth RS, McCutchan JA.

Ann Intern Med. 1993 Aug 1;119(3):241-3. No abstract available.

PMID:
8100694
38.

Mechanisms for the inhibition of HIV replication by interferons-alpha, -beta, and -gamma in primary human macrophages.

Meylan PR, Guatelli JC, Munis JR, Richman DD, Kornbluth RS.

Virology. 1993 Mar;193(1):138-48.

PMID:
7679856
39.

HIV infection of the lung. Role of virus-infected macrophages in the pathophysiology of pulmonary disease.

Meltzer MS, Kornbluth RS, Hansen B, Dhawan S, Gendelman HE.

Chest. 1993 Feb;103(2 Suppl):103S-108S. Review. No abstract available.

PMID:
8428524
40.

Recovery of infectious HIV following the passage of apoptotic cellular debris through phagocytic macrophages.

Kornbluth RS, Rhodes J, Richman DD.

Chest. 1993 Feb;103(2 Suppl):102S-103S. No abstract available.

PMID:
8428523
41.

Ordered appearance of human immunodeficiency virus type 1 nucleic acids following high multiplicity infection of macrophages.

Munis JR, Kornbluth RS, Guatelli JC, Richman DD.

J Gen Virol. 1992 Aug;73 ( Pt 8):1899-906.

PMID:
1645135
42.

Oxygen tensions and mycobacterial infections.

Meylan PR, Richman DD, Kornbluth RS.

Clin Infect Dis. 1992 Aug;15(2):372-3. No abstract available.

PMID:
1520772
43.

Reduced intracellular growth of mycobacteria in human macrophages cultivated at physiologic oxygen pressure.

Meylan PR, Richman DD, Kornbluth RS.

Am Rev Respir Dis. 1992 Apr;145(4 Pt 1):947-53.

PMID:
1554224
44.
45.

HIV infectivity is not augmented by treatment with trypsin, Factor Xa or human mast-cell tryptase.

Meylan PR, Tam EK, Kornbluth RS, Richman DD.

AIDS. 1992 Jan;6(1):128-30. No abstract available.

PMID:
1543555
46.

Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1.

Terai C, Kornbluth RS, Pauza CD, Richman DD, Carson DA.

J Clin Invest. 1991 May;87(5):1710-5.

48.
50.

The effects of gamma-interferon on human peripheral blood monocyte/macrophage-mediated bone particle degradation.

Terkeltaub R, Firestein GS, Kornbluth RS, Martin J, Curran D, Manolagas S.

Bone Miner. 1990 Feb;8(2):131-43.

PMID:
2106359

Supplemental Content

Loading ...
Support Center